CytoDyn Inc. Share Price Other OTC
Equities
CYDY
US23283M1018
Biotechnology & Medical Research
Sales 2022 | 0.27 21.25 | Sales 2023 | - | Capitalization | 239M 19.13B |
---|---|---|---|---|---|
Net income 2022 | -211M -16.86B | Net income 2023 | -79M -6.31B | EV / Sales 2022 | 989,524,989 x |
Net Debt 2022 | 32.57M 2.6B | Net Debt 2023 | 33.01M 2.64B | EV / Sales 2023 | - |
P/E ratio 2022 |
-1.02
x | P/E ratio 2023 |
-2.52
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 99.15% |
Latest transcript on CytoDyn Inc.
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 64 | 11-16 | |
Mitchell Cohen
DFI | Director of Finance/CFO | 68 | 01-31 |
Scott Hansen
CTO | Chief Tech/Sci/R&D Officer | - | 02/05/23 |
Members of the board | Title | Age | Since |
---|---|---|---|
Stephen Simes
BRD | Director/Board Member | 72 | 12/10/22 |
Ryan Dunlap
BRD | Director/Board Member | 54 | 23/08/22 |
Karen Brunke
BRD | Director/Board Member | 72 | 31/03/22 |
1st Jan change | Capi. | |
---|---|---|
-2.84% | 102B | |
+1.91% | 96.29B | |
+1.86% | 22.18B | |
-15.24% | 21.2B | |
-9.03% | 18.31B | |
-39.98% | 17.38B | |
-14.12% | 16.36B | |
+5.28% | 13.97B | |
+32.19% | 12.17B |